Semaglutide studies: 1,194 papers with results
Page 24 of 24
- Comparative efficacy and safety of glucagon-like peptide 1 based drugs for weight loss in adults with overweight or obesity without diabetes: network meta-analysis of randomised controlled trials.
Chen D · BMJ medicine · 2026
Not a test of Semaglutide alone · 7 results
- Preferences for Obesity Medications Among People With Overweight or Obesity in the United States: A Discrete-Choice Experiment (OPTIC).
Almandoz JP · Diabetes, obesity & metabolism · 2026
Not a test of Semaglutide alone · 4 results
- Diverse Obesity Trajectories in a Family Including Identical Twins with a Pathogenic MC4R Variant.
Lim JJX · Obesity facts · 2025
Not a test of Semaglutide alone · 2 results
- Interventions for prediabetes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials.
Veronese N · Diabetes & metabolic syndrome · 2025
Not a test of Semaglutide alone · 5 results
- Case report of a female western Indian vegetarian with obesity.
Niranjan V · Obesity pillars · 2024
Not a test of Semaglutide alone · 2 results
- Benchmarking the medication efficiency and technological progress of diabetes drugs.
Zhang H · Frontiers in public health · 2024
Not a test of Semaglutide alone · 4 results
- Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes.
Storgaard H · Diabetes, obesity & metabolism · 2017
Not a test of Semaglutide alone · 2 results
- Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials.
Monami M · Diabetes research and clinical practice · 2014
Not a test of Semaglutide alone · 1 result
- Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials.
Monami M · Journal of endocrinological investigation · 2017
Not a test of Semaglutide alone · 2 results
- A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point?
Docimo S Jr · Surgical endoscopy · 2024
Not a test of Semaglutide alone · 2 results
- A Systematic Review of Semaglutide's Influence on Cognitive Function in Preclinical Animal Models and Cell-Line Studies.
Tipa RO · International journal of molecular sciences · 2024
Not a test of Semaglutide alone · 1 result
- Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review.
Alsaqaaby MS · The lancet. Diabetes & endocrinology · 2024
Not a test of Semaglutide alone · 6 results
- Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: Systematic review and network meta-analysis.
Koh B · Hepatology (Baltimore, Md.) · 2026
Not a test of Semaglutide alone · 1 result
- What the diabetologist needs to know about the risk of non-arteritic anterior ischaemic optic neuropathy and GLP-1 receptor agonist use in patients with type 2 diabetes.
Feldman-Billard S · Diabetes & metabolism · 2025
Not a test of Semaglutide alone · 1 result
- A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes Mellitus.
Laursen HVB · PharmacoEconomics · 2023
Not a test of Semaglutide alone · 1 result
- A Retrospective Observational Study Examining the Generalizability of Glucagon-Like Peptide 1 Receptor Agonist Cardiovascular Outcome Trials to the Real-World Population with Type 2 Diabetes in Spain: The REPRESENT Study.
Romera I · Advances in therapy · 2022
Not a test of Semaglutide alone · 2 results
- Compounded glucagon-like peptide-1 receptor agonists for weight loss: the direct-to-consumer market in Colorado.
DiStefano MJ · Journal of pharmaceutical policy and practice · 2025
Not a test of Semaglutide alone · 5 results
- Gastrointestinal Adverse Effects of Anti-Obesity Medications in Non-Diabetic Adults: A Systematic Review.
Takrori E · Medicina (Kaunas, Lithuania) · 2025
Not a test of Semaglutide alone · 4 results
- Evaluating bowel obstruction and ileus events in patients on GLP-1 receptor agonists: a systematic review and meta-analysis.
Alfehaid L · Expert opinion on drug safety · 2026
Not a test of Semaglutide alone · 3 results
- Incretin Dominance and Emerging Mechanisms in Obesity Pharmacotherapy: Insights from 275 Registered Clinical Trials (2019-2024).
Dos Santos Barbosa LA · Therapeutic innovation & regulatory science · 2026
Not a test of Semaglutide alone · 2 results
- Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials.
Ciudin A · Advances in therapy · 2026
Not a test of Semaglutide alone · 24 results
- Weight Loss From Combination Anti-Obesity Medication Regimens Can Approach that Achieved From Bariatric Surgery.
Patel PN · JCEM case reports · 2023
Not a test of Semaglutide alone · 1 result
- The effect of GLP-1 receptor agonists on autophagy: insights gathered from research evaluating neurodegenerative disorders with these agents.
Sioufi MC · Acta neuropsychiatrica · 2026
Not a test of Semaglutide alone · 2 results
- Efficacy of antiobesity medications for weight reduction in older adults: a systematic review.
Chen AS · Obesity (Silver Spring, Md.) · 2025
Not a test of Semaglutide alone · 1 result
- Short- and long-term glycemic effects of pasireotide in patients with acromegaly: a comprehensive case study with review of literature.
Taki Y · Endocrine journal · 2025
Not a test of Semaglutide alone · 1 result
- Glucagon-like Peptide-1 receptor agonist use is not associated with increased reoperation risk following rotator cuff repair.
Rasmussen ST · Journal of orthopaedics · 2025
Not a test of Semaglutide alone · 3 results
- Exploring the Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Genitourinary Toxicities in Prostate Cancer Patients Undergoing Radiation Therapy: A Case Study and Discussion.
Andrianu K · Practical radiation oncology · 2024
Not a test of Semaglutide alone · 1 result
- FDG PET in a Patient on a GLP-1 Agonist/Insulin Secretagogue.
Oldan JD · Clinical nuclear medicine · 2024
Not a test of Semaglutide alone · 1 result
- Case Series of Nizon-Isidor Syndrome by Heterozygous Variants in MED12L With Further Evidence of Mitotic Instability in One Case With Diploid-Triploid Mosaicism.
Stewart R · American journal of medical genetics. Part A · 2026
Not a test of Semaglutide alone · 2 results
- GLP-1 agonist-associated presentations to unscheduled care: An opportunistic pilot study.
Thomas O · British journal of clinical pharmacology · 2026
Not a test of Semaglutide alone · 2 results
- A Novel Presentation of Euglycemic Diabetic Ketoacidosis Associated with SGLT2 Inhibitor and Weekly GLP-1 Agonist: Case Report.
Lyu YS · Healthcare (Basel, Switzerland) · 2025
Not a test of Semaglutide alone · 1 result
- Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial.
Liu X · Journal of diabetes investigation · 2024
Not a test of Semaglutide alone · 1 result
- Hypoglycaemic coma induced by a falsified semaglutide product: a case report.
Antonacci G · European journal of hospital pharmacy : science and practice · 2026
Not a test of Semaglutide alone · 1 result
- Progression to type 2 diabetes among post-myocardial infarction patients with overweight or obesity: a real-world cohort study.
Tonnesen PT · Cardiovascular diabetology · 2026
Not a test of Semaglutide alone · 1 result
- Pancreatic Mucinous Cystic Neoplasms Following GLP-1 Receptor Agonists Use: A Report of Two Cases with Literature Review.
Alsaleh NM · Journal of gastrointestinal cancer · 2026
Not a test of Semaglutide alone · 1 result
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report.
Elliott DC · Cureus · 2026
Not a test of Semaglutide alone · 1 result
- A Clinical Comprehensive Evaluation of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes Management.
Chen Q · Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
Not a test of Semaglutide alone · 2 results
- Metabolic and nutritional stress-associated dilated cardiomyopathy in the setting of semaglutide use and long-term nicotine replacement therapy: a case report and literature review.
Sriram S · Therapeutic advances in drug safety · 2026
Not a test of Semaglutide alone · 1 result
- Type B insulin resistance with glycemic extremes: a case report and literature review.
Ngo EMT · Frontiers in endocrinology · 2026
Not a test of Semaglutide alone · 1 result
- Peripheral nerve complications from medications utilised for weight loss: a systematic review.
O'Gorman C · Journal of neurology · 2026
Not a test of Semaglutide alone · 2 results
- Herpes Zoster Occurring After Injection of Botulinum Toxin and Hyaluronic Acid.
Liang Y · The Journal of craniofacial surgery · 2025
Not a test of Semaglutide alone · 1 result
- Case Report: long-term misdiagnosis and follow-up of a patient with HNF4A-MODY carrying a new de novo mutation.
Luo J · Frontiers in endocrinology · 2025
Not a test of Semaglutide alone · 1 result
- Nonoperative Case of Acute Type A Aortic Dissection in a Young Patient.
El-Andari R · JACC. Case reports · 2025
Not a test of Semaglutide alone · 1 result
- Blurring Fact and Fiction: A Complex Case of Recurrent Emergency Presentations, Polypharmacy, and Psychiatric Conflict.
Reyad B · Cureus · 2025
Not a test of Semaglutide alone · 1 result